10 dose

Excels in fetal protection, while maintaining its superior safety for use in pregnant cows and calves nursing pregnant cows. At 1,000-times normal dose levels, there was no shedding, no fever, no illness, no transmission, no immune suppression and no side effects. The BVD Type 1and the highly researched new BVD Type 2 strain are developed in a patent-pending non-recombination technology to ensure they do not have the potential to recombine to form noncytopathic mutants that can cause fetal infection.
Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine